Insider Transactions in Q4 2023 at Sagimet Biosciences Inc. (SGMT)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 07
2023
|
David Happel President & CEO |
BUY
Open market or private purchase
|
Direct |
1,600
+0.25%
|
$6,400
$4.1 P/Share
|
|
Nov 17
2023
|
Eduardo Bruno Martins Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
89,570
+50.0%
|
-
|
|
Nov 17
2023
|
David Happel President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
624,910
+49.98%
|
-
|
|
Nov 17
2023
|
George Kemble Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
150,750
+49.08%
|
-
|
|
Nov 17
2023
|
Elizabeth Rozek General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
171,420
+50.0%
|
-
|
|
Nov 16
2023
|
David Happel President & CEO |
BUY
Open market or private purchase
|
Direct |
590
+50.0%
|
$1,180
$2.35 P/Share
|